Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Variable | HR (CI 95%) | P-Value | HR (CI 95%) | P-Value |
Age (years) | 1.052 (1.032–1.072) | <0.001 | 1.031 (1.002–1.06) | 0.036 |
Charlson Comorbidity Index | 1.305 (1.194–1.427) | <0.001 | 1.254 (1.075–1.462) | 0.004 |
Previous cardiovascular disease (yes/no) | 2.185 (1.30–3.65) | 0.003 | - | |
Incident cardiovascular disease (yes/no) | 2.654 (1.646–4.279) | <0.001 | - | |
Left Ventricular Hypertrophy (yes/no) | 1.764 (1.093–2.845) | 0.002 | - | |
Previous Kidney Transplant (yes/no) | 0.374 (0.186–0.751) | 0.006 | - | |
Interdialytic weight gain (kg) | 0.764 (0.579–1.007) | 0.056 | - | |
Dyslipidaemia (yes/no) | 1.255 (0.793–1.985) | 0.332 | - | |
Diabetes Mellitus (yes/no) | 1.401 (0.861–2.28) | 0.174 | - | |
Hypertension (yes/no) | 1.32 (0.606–2.878) | 0.485 | - | |
Smoking (yes/no) | 2.185 (1.376–3.47) | 0.001 | 2.122 (1.251–3.599) | 0.005 |
Systolic Blood Pressure (mmHg) | 0.993 (0.983–1.004) | 0.191 | - | |
Diastolic Blood Pressure (mmHg) | 0.975 (0.957–0.994) | 0.010 | - | |
Mean Blood Pressure (mmHg) | 0.983 (0.968–0.999) | 0.032 | - | |
Statin treatment (yes/no) | 1.516 (0.929–2.473) | 0.096 | - | |
Osteoprotegerin (highesttertile) | 1.9 (1.203–2.999) | 0.006 | 1.957 (1.123–3.411) | 0.018 |
Calcium (mg/dl) | 1.136 (0.9–1.434) | 0.284 | - | |
Phosphate (mg/dl) | 0.868 (0.745–1.013) | 0.072 | - | |
iPTH (pg/ml) | 0.999 (0.998–1.000) | 0.114 | - | |
Fetuin-A (ng/ml) | 0.994 (0.984–1.004) | 0.230 | - | |
Albumin (g/l) | 0.884 (0.844–0.925) | <0.001 | 0.886 (0.837–0.937) | < 0.001 |
C-reactive protein (mg/dl) | 1.17 (1.09–1.252) | <0.001 | - | |
Adiponectin (μg/ml) | 1.003 (0.973–1.033) | 0.867 | - | |
IL-18 (pg/ml) | 1.0 (1.00–1.001) | 0.011 | 1.061 (1.036–1.087) | <0.001 |
Troponin I (ng/ml) | 12.626 (3.795–42.01) | <0.001 | 3.894 (1.048–14.462) | 0.042 |
BNP (pg/ml) | 1.0 (1.0–1.001) | 0.001 | - | |
LV ejection fraction (%) | 0.966 (0.945–0.987) | 0.002 | - |